Cadrenal Therapeutics, Inc. /
Veralox Therapeutics Inc.
Cadrenal Therapeutics, Inc. agrees to buy Veralox Therapeutics Inc.
Source for the buyer and target: Cadrenal Therapeutics, Inc.
For the buyer and target.
“THIS ASSET PURCHASE AGREEMENT (this “ Agreement ”) is made as of December 10, 2025 (the “ Execution Date ”) by and between Cadrenal Therapeutics, Inc. , a Delaware corporation (“ Purchaser ”), and VERALOX THERAPEUTICS Inc. , a Delaware corporation (“ Seller ”).”
Published 11 Dec 2025
Open the sourceWhat happened
Cadrenal Therapeutics, Inc. agreed to acquire Veralox Therapeutics Inc. for a cash payment of $200,000, according to a filing dated Dec. 11, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Cadrenal Therapeutics, Inc. agrees to buy Veralox Therapeutics Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Cadrenal Therapeutics, Inc. agrees to buy Veralox Therapeutics Inc. Cadrenal Therapeutics, Inc. agreed to acquire Veralox Therapeutics Inc. for a cash payment of $200,000, according to a filing dated Dec. 11, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly